22157.jpg
Global Biotech Partnering Deals, Terms and Agreements Report 2016-2020
September 14, 2020 07:28 ET | Research and Markets
Dublin, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The "Global Biotech Partnering Terms and Agreements 2016-2020" report has been added to ResearchAndMarkets.com's offering. Global Biotech Partnering...
Cytovia.png
Cytovia Therapeutics Licenses Productivity-Boosting Manufacturing Technology for Its NK Engager Multifunctional Antibodies From ProteoNic
August 12, 2020 09:04 ET | Cytovia Therapeutics
NEW YORK and LEIDEN, the Netherlands, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc (Cytovia), an emerging biopharmaceutical company developing CAR NK cell therapy and NK engager...
University of Oregon
University of Oregon Department of Human Physiology Approved for Funding from ARCS® Foundation
May 19, 2020 15:28 ET | ARCS Foundation Inc.
LaGrange, GA, May 19, 2020 (GLOBE NEWSWIRE) -- ARCS® Foundation is pleased to announce the addition of University of Oregon’s Department of Human Physiology to its approved departments for funding. ...
University of Minnesota Department of Neuroscience Approved for Funding from ARCS Foundation
April 15, 2020 11:09 ET | ARCS Foundation Inc.
LaGrange, GA, April 15, 2020 (GLOBE NEWSWIRE) -- ARCS® Foundation is pleased to announce it has approved adding the Department of Neuroscience within the University of Minnesota Medical School to...
Cytovia.png
CYTOVIA Therapeutics and the New York Stem Cell Foundation Research Institute enter into a partnership to develop iPSC derived CAR NK Therapeutics
January 09, 2020 08:00 ET | Cytovia Therapeutics
NEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) -- The New York Stem Cell Foundation (NYSCF) Research Institute today announced a partnership with Cytovia Therapeutics Inc. (Cytovia) to develop new disease...
Cytovia Therapeutics and the University of California, San Francisco enter into a partnership to develop precision gene-edited CAR-NK cell therapy
January 06, 2020 08:00 ET | Cytovia Therapeutics
SAN FRANCISCO and NEW YORK, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, a biopharmaceutical company, and the University of California, San Francisco (UCSF) announced today that they have...
energias.jpg
Global Regenerative Medicine Market to Witness a CAGR of 20.5% during 2018-2024
March 18, 2019 10:37 ET | Energias Market Research
NEW YORK, March 18, 2019 (GLOBE NEWSWIRE) -- Global regenerative medicine market is expected to reach USD 79.8 billion by 2024, at a CAGR of 20.5% from 2018 to 2024. Factors driving the growth of...
FLYWHEEL LOGO.png
Flywheel Partners with Google Cloud to Provide Clinical Researchers with Advanced Cloud Technology and Machine Learning for Medical Imaging
February 11, 2019 07:00 ET | Flywheel
MINNEAPOLIS and MOUNTAIN VIEW, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- Flywheel, provider of cloud-based collaborative science solutions for biomedical research, today announced a technology...
Keystone Symposia Announces Dr. Deborah Johnson as New President and Chief Executive Officer
October 30, 2018 10:00 ET | Keystone Symposia on Molecular & Cellular Biology
Silverthorne, Colorado, USA, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Dr. Deborah L. Johnson of Baylor College of Medicine has been named President and Chief Executive Officer of Keystone Symposia. A...
Nikon Instruments Logo
BIO and Nikon Instruments Inc. Jointly announce a new Program for Research Grade Microscope System for BIO Members
June 29, 2016 10:58 ET | Nikon Instruments
WASHINGTON, June 29, 2016 (GLOBE NEWSWIRE) -- The Biotechnology Innovation Organization (BIO) and Nikon Instruments Inc. jointly announce a new partnership under the BIO Business Solutions®...